Omeros | OMER - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Adma Biologics USD 1.63M 54K 2025-12
Alnylam Pharmaceuticals USD 69.29M 60.05M 2026-03
BioMarin Pharmaceutical USD 14.96M 12.18M 2026-03
Cytokinetics USD 33.34M 3M 2026-03
Gilead Sciences USD 240M 15M 2026-03
Heron Therapeutics USD 600K 100K 2024-12
Immunic 197K 222K 2025-12
Insmed USD 20.08M 517K 2026-03
Knight Therapeutics CAD 3.92M 1.56M 2025-12
MacroGenics USD 3.34M 2.54M 2025-09
Omeros USD 4.05M 5.16M 2024-09
Pacira USD 3.7M 193K 2026-03
Pfizer USD 671M 40M 2026-03
Rockwell Medical USD 232K 199K 2024-06
Sangamo BioSciences 97.56M 11.39M 2025-06
Sarepta Therapeutics USD 20.84M 13.28M 2025-12
United Therapeutics USD 3.1M 100K 2025-12
Vertex Pharmaceuticals USD 3.3M 0 2025-12
Xoma USD 3.4M 150K 2024-06